FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations
NEWS & BLOGS
FDA Approves First Biosimilar to Treat Macular Degeneration Disease
FDA authorizes baricitinib alone as treatment for COVID-19
FDA Approves Pfizer-BioNTech COVID-19 Vaccine as The First COVID-19 Vaccine
Pfizer Issues a Voluntary Nationwide Recall of CHANTIX® Tablets Due to N-Nitroso Varenicline Content
Johnson & Johnson Issues Voluntary Recall of Sunscreen Products Due to the Presence of Benzene
Class action lawsuit filed over hair care products causing baldness and scalp damage
South Korea's Response to COVID-19
OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2021 User Fees Webinar
FDA Warns Not Using Certain Needles With Safety Devices Made by HAIOU
FDA authorizes use of the Pfizer-BioNTech Covid Vaccine in adolescents ages 12 to 15
FDA Approves Treatment for Chronic Kidney Disease
Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
New OTC Monograph User Fees for FY2021 is Announced
FDA Alerts Public about Improper Use of Thermal Imaging Devices
FDA Granted Marketing Authorization of First COVID-19 Diagnostic Test Using De Novo Review Pathway
Homemade Infant Formula is not recommended by the FDA
FDA Warns Seriously Toxic Hand Sanitizers Imported from Mexico
FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV
Over 300 COVID-19 Tests and Collection Kits Authorized by the FDA in 2020